Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Recent Strategies and Future Recommendations for the Fabrication of Antimicrobial, Antibiofilm, and Antibiofouling Biomaterials
Biomaterials and biomedical devices induced life-threatening bacterial infections and other
biological adverse effects such as thrombosis and fibrosis have posed a significant threat to …
biological adverse effects such as thrombosis and fibrosis have posed a significant threat to …
Heparin-induced thrombocytopenia: An illustrated review
J May, B Westbrook, A Cuker - Research and Practice in Thrombosis …, 2023 - rpthjournal.org
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug effect from
unfractionated or low-molecular-weight heparin that results in thrombocytopenia and …
unfractionated or low-molecular-weight heparin that results in thrombocytopenia and …
Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study
S Doubrovinskaia, CM Mooshage… - European journal of …, 2023 - Wiley Online Library
Background and purpose Population‐based studies suggest severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) vaccines may trigger neurological autoimmunity …
syndrome coronavirus 2 (SARS‐CoV‐2) vaccines may trigger neurological autoimmunity …
[HTML][HTML] A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study
Background Diagnosing heparin-induced thrombocytopenia (HIT) at the bedside remains
challenging, exposing a significant number of patients at risk of delayed diagnosis or …
challenging, exposing a significant number of patients at risk of delayed diagnosis or …
New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry
Background Heparin-induced thrombocytopenia (HIT) is a serious complication caused by
heparin drugs. The ultralarge complexes formed by platelet factor 4 (PF4) with heparin or …
heparin drugs. The ultralarge complexes formed by platelet factor 4 (PF4) with heparin or …
[HTML][HTML] Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of …
L Liu, H Zheng, S Chen, S Wang, M Yang - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: Unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are
commonly used anticoagulants for the management of arterial and venous thromboses …
commonly used anticoagulants for the management of arterial and venous thromboses …
[HTML][HTML] Novel knowledge about molecular mechanisms of heparin-induced thrombocytopenia type II and treatment targets
A Mongirdienė, A Liuizė, A Kašauskas - International Journal of …, 2023 - mdpi.com
Heparin-induced thrombocytopenia type II (HIT II), as stated in the literature, occurs in about
3% of all patients and in 0.1–5% of surgical patients. Thrombosis develops in 20–64% of …
3% of all patients and in 0.1–5% of surgical patients. Thrombosis develops in 20–64% of …
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study
JB Giles, J Rollin, KL Martinez, K Selleng, T Thiele… - Thrombosis …, 2023 - Elsevier
Heparin-induced thrombocytopenia (HIT) is an antibody-mediated immune response
against platelet factor 4 (PF4) bound to heparin anticoagulants. A priori identification of …
against platelet factor 4 (PF4) bound to heparin anticoagulants. A priori identification of …
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study
A Hammerer-Lercher, H Nilius, JD Studt… - Journal of Thrombosis …, 2023 - Elsevier
Background Anecdotal reports suggest that the correlation between heparin/platelet factor 4
(PF4) antibody assays for the diagnosis of heparin-induced thrombocytopenia (HIT) is …
(PF4) antibody assays for the diagnosis of heparin-induced thrombocytopenia (HIT) is …